Mumbai, Feb. 24 -- A clutch of global private equity firms, including General Atlantic, KKR and CVC Capital Partners among others, are evaluating a minority stake in India Resurgence Fund-backed Synthimed Labs Pvt. Ltd (SLPL), as the pharmaceutical ingredients maker prepares for a public listing, three people familiar with the matter said.

"IndiaRF will sell a minority stake to raise $150-200 million as the company prepares for an IPO," one of the people cited above. Several funds were tapped as a part of the process, a second person said.

In December, Mint first reported that IndiaRF has mandated Rothschild to help scout for buyers for the portfolio company that is seeking a valuation of about $1 billion.

The stake sale underscores ri...